SNES — SenesTech Inc
NASDAQ · Basic Materials · Specialty Chemicals
$1.07
-$0.01 (-0.63%)
SenesTech Inc (SNES) is a specialty chemicals company listed on NASDAQ. It is led by Joel L. Fruendt, based in 777 West Pinnacle Peak Road, Phoenix, AZ, United States, 85027, with about 23 employees. SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption. The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Latest reported SNES revenue for 2025-09-30 was $690.0K. Net income was -$1.3M. Revenue was up 10.4% from 2025-06-30 to 2025-09-30. SNES currently screens at market cap $10.4M.
Use this SNES page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SNES quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SNES SEC filings page. Lician reads the product cache first so this HTML stays unique to SenesTech Inc even when a live quote feed is slow.
About SenesTech Inc
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice after one to two breeding cycles following consumption. The company also provides teleconsulting and technical advisory services. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SNES Key Statistics
Market Cap
$10.36M
Volume
29,441
Previous Close
$1.19
Day Range
$1.16 – $1.21
EPS
-$8.86
Revenue
$1.86M
Net Income
-$6.18M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+55.7%
Profit Margin
-333.0%
Employees
23
SNES Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.86M | $1.19M | $1.02M | $600.00K |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$6.18M | -$7.71M | -$9.70M | -$8.27M |
| EPS (Diluted) | -$8.86 | -$115.10 | -$148.08 | -$14.77 |
Total Assets
$3.28M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$1.31M
Operating Cash Flow
-$6.03M
Free Cash Flow
$0.00
SenesTech Inc Company Information
- CEO, President & Director
- Joel L. Fruendt
- Headquarters
- 777 West Pinnacle Peak Road, Phoenix, AZ, United States, 85027
- Website
- www.senestech.com
- Phone
- 928 779 4143
- IPO / Founded
- 2016-12-08
- Sector
- Basic Materials
- Industry
- Specialty Chemicals